Overview


According to FutureWise analysis the market for High Throughput Screening in 2023 is US$ 18 billion, and is expected to reach US$ 33 billion by 2031 at a CAGR of 8%.

A drug discovery approach known as high-throughput screening (HTS) allows for the automated evaluation of many chemical and/or biological molecules for the presence of a certain biological target. In the pharmaceutical business, high-throughput screening techniques are frequently used to rapidly examine the biological or biochemical activity of a large number of compounds. These techniques make use of robots and automation. High-throughput screening enables a researcher to quickly carry out millions of genetic, chemical, or pharmacological experiments using robotics, liquid handling equipment, data processing/control software, and sensitive detectors.

The number of high-throughput screening devices that are open to the public has significantly increased during the last several years. The scale of these facilities ranges from sizable molecular libraries and probe centre networks to modestly equipped university screening facilities. In order to conduct primary and secondary screening campaigns, these facilities employ both traditional and advanced assay technologies, offering a full way of probe discovery in educational institutions. The market is influenced by the growing use of high-throughput screening for developing drugs, which shortens the time needed to produce a medicine, and by an increase in government financing for the adoption of new technologies like CRISPR-Cas9 and RNAi and artificial intelligence, among others. Additionally, the high throughput screening market is favourably impacted by increases in healthcare spending, disposable income, end-of-use industries, and awareness.

FutureWise Market Research has published a report that provides an insightful analysis of High throughput screening market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that the High throughput screening market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Thermo Fisher Scientific
  • Agilent Technologies Inc
  • Danaher
  • PerkinElmer Inc
  • Tecan Group Ltd
  • Axxam S.p.A
  • Bio-Rad Laboratories Inc
  • Merck Group KGaA
  • Hamilton Company
  • Corning Incorporated
  • Biotek Instruments Inc
  • Aurora Biomed Inc

Recent developments by key players in High throughput screening market:

In December 2022, Metrion Biosciences Limited ("Metrion"), a contract research and drug development firm with a focus on ion channels, has announced the launch of its High Throughput Screening (HTS) capacity and expand its cutting-edge lab and office space. The new service's Head of HTS has been named Scott Maidment.

The rise in the usage of high-throughput screening for drug development, since it saves time which is required to develop a drug, are just a few of the forces influencing the growth of the worldwide high throughput screening market during the forecast period. The creation of novel medications to treat various illnesses that are life-threatening and the government's support for the use of cutting-edge technologies including the microplate-free approach, CRISPR-Cas9 & RNAi, and artificial intelligence & machine learning also contributes to the market's expansion. Faster data processing and increased automation in the area of high throughput screening also contributes towards target market’s growth. But there are also barriers that impede development, like large capital expenditures and a shortage of skilled professionals with the necessary skills in less developed nations. These factors are expected to fuel the market growth of high throughput screening, further boosting revenue for this target market.

By Products and Services

  • Products
    • Reagents and Assay Kits
    • Instruments
    • Software
  • Services

By Technology

  • Cell-Based Assays
    • Cell Proliferation Assays 
    • Cell Viability Assays 
    • Cell Cytotoxicity Assays 
    • Cell Death Assays 
    • Other Cell-Based Assays
  • Lab-on-a-Chips
    • PDMS
    • Thermopolymers
    • Glass
    • Silicon
    • Paper
  • Ultra high throughput Screening 
    • Chip-based Screening 
    • Micro-channel Flow Systems 
    • Plateless Systems
    • Others
  • Label-Free Technology 
    • SPR
    • ITC
    • Others

By Application

  • Drug Discovery
    • Medicinal Chemistry
    • Biology Services
    • Drug Metabolism and Pharmacokinetics (DMPK)
  • Chemical Biology Programs
    • Cellular & Biological Simulation
    • Disease Modelling 
    • Preclinical Drug Development 
    • Clinical Trials 
  • Cell & Organ-Based Screening
    • Drug Discovery 
    • Academic Research 
  • Biochemical Screening
    • Blood and Blood –based Products 
    • Vaccines and Therapeutics
    • Stem Cells 
  • Biological Active Compound Screening 
    • Target Identification 
    • Primary Screening
    • Toxicology 
  • Genomics
    • Diagnostic Application
    • Precision Medicine
  • Proteomics
    • Drug Diagnostics
    • Precision Medicine
  • Compound Profiling
    • Drug Discovery
    • Cancer/Tumor Profiling 
    • Toxicology 

By Detection Method

  • Mass Spectrometry 
    • Surface-based MALDI-MS
    • LASI-MS Imaging 
    • Injection-based MS
    • Others
  • Chromatography 
    • HIC
    • HPLC
    • SEC
    • HPGC
    • Others
  • Calorimetry
    • Rapid Mass Calorimeter
    • ITC
    • Nanocalorimetry
    • Array Calorimetry
    • Others
  • X-ray Diffraction
    • In situ Crystallization 
    • In meso Crystallization 
    • Crystal X-ray Diffraction 
    • Others

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations (CRO)
  • Others    

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America  
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the rising use of high-throughput screening, rising R&D spending, growing developments in genomics and combinatorial chemistry, and significant investments made by the pharmaceutical industry in high-throughput screening technologies in terms of automation, miniaturization, and assay methodology, North America is anticipated to account for a sizeable portion of the global market for high-throughput screening. Additionally, based on technology; Cell based Assay (46.8%), Lab-on-chip (32.9%), Ultra high through put screening (10.5%), label Free technology (9.8%) hold corresponding market shares in 2022 in the global market.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the High Throughput Screening Market By Products and Services, By Technology, By Application, By Detection Method, By End-User, By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   High Throughput Screening Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of High Throughput Screening Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   High Throughput Screening Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   High Throughput Screening Market, By Products and Services Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Products
         1.1. Reagents and Assay Kits
         1.2. Instruments
         1.3. Software
        2. Services

  • 8.   High Throughput Screening Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

    •      1. Cell-Based Assays
         1.1. Cell Proliferation Assays
         1.2. Cell Viability Assays
         1.3. Cell Cytotoxicity Assays
         1.4. Cell Death Assays
         1.5. Other Cell Based Assays
        2. Lab-on-a-Chip
         2.1. PDMS
         2.2. Thermopolymers
         2.3. Glass
         2.4. Silicon
         2.5. Paper
        3. Ultra High Throughput Screening
         3.1. Chip-based Screening
         3.2. Micro-channel Flow Systems
         3.3. Platess Systems
         3.4. Others
        4. Label Free Technology
         4.1. SPR
         4.2. ITC
         4.3. Others

  • 9.   High Throughput Screening Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •         1. Drug Discovery
         1.1. Medicinal Chemistry
         1.2. Biology Services
         1.3. Drug Metabolism and Pharmacokinetics (DMPK)
              2. Chemical Biology Programs
         2.1. Cellular & Biological Simulation
         2.2. Disease Modelling
         2.3. Preclinical Drug Development
         2.4. Clinical Trials
         3. Cell & Organ-Based Screening
         3.1. Drug Discovery
         3.2. Academic Research
        4. Biochemical Screening
         4.1. Blood and Blood –based Products
         4.2. Vaccines and Therapeutics
         4.3. Stem Cells
         5. Biological Active Compound Screening
         5.1. Target Identification
         5.2. Primary Screening
         5.3. Toxicology
         6. Genomics
         6.1. Diagnostic Application
         6.2. Precision Medicine
         7. Proteomics
         7.1. Drug Diagnostics
         7.2. Precision Medicine
         8. Compound Profiling
         8.1. Drug Discovery
         8.2. Cancer/Tumor Profiling
         8.3. Toxicology 

  • 10.   High Throughput Screening Market, By Detection Method Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Mass Spectroscopy
         1.1. Surface-based MALDI-MS
         1.2. LASI-MS Imaging
         1.3. Injection-based MS
         1.4. Others
        2. Chromatography
         2.1. HIC
         2.2. HPLC
         2.3. SEC
         2.4. HPGC
         2.5. Others
        3. Calorimetry
         3.1. Rapid Mass Calorimeter
         3.2. ITC
         3.3. Nanocalorimetry
         3.4. Array Calorimetry
         3.5. Others
        4. X-Ray Diffraction
         4.1. in situ Crystallization
         4.2. in meso Crystallization
         4.3. Crystal X-ray Diffraction
         4.4. Others
        5. Others

  • 11.   High Throughput Screening Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Pharmaceutical and Biotechnology Companies
        2. Academic and Government Institutes
        3. Contract Research Organizations (CRO)
        4. Others  

  • 12.   North America High Throughput Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America High Throughput Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe High Throughput Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific High Throughput Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Agilent Technologies Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Danaher
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. PerkinElmer Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Tecan Group Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Axxam S.p.A.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bio-Rad Laboratories Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Merck Group KGaA
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Hamilton Company
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Corning Incorporated
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Biotek Instruments Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Aurora Biomed Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client

FAQ


Key drivers include the increasing incidence of chronic diseases, demand for new drug development, growing Research and development spending, technological advances, and the entry of private and public funding in life sciences research.

High-throughput screening (HTS) is an automated process that allows researchers to quickly conduct millions of chemical, genetic, or pharmacological tests. Its rapid nature helps identify active compounds, antibodies, or genes that can be further used for drug and therapeutic development. Its efficiency benefits the pharmaceutical and biotechnology industries by accelerating the discovery process and reducing the time and cost associated with research and development.

The market size for high-throughput screening is substantial, with a multi-billion dollar valuation that is expected to grow at a steady rate. Factors such as increasing research and development investment, technological advancements, and the growing demand for drug discovery are driving this growth. The precise figures may vary, and consulting a recent market research report would provide the latest estimates.

Major challenges include high initial setup costs, the complexity of data analysis, and the need for specialized expertise. Companies can overcome these barriers by outsourcing to specialized service providers, collaborating with academic institutions, or investing in training their personnel.

Yes, emerging technologies include next-generation sequencing, clustered regularly interspaced short palindromic repeats, and AI-driven predictive analysis tools. These technologies are refining the screening process, increasing the accuracy of results, and decreasing turnaround times.

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11